Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone

Summary

The purpose of the study is to compare the efficacy of treatment with afatinib plus letrozole to treatment with letrozole alone in women diagnosed with a specific type of breast cancer.

Timeline

Start

2014-07

Primary completion

2018-11

Completion

2018-11

Outcome

Outcome not reported

Stopped (Enrollment): “Study was completed as per amended protocol. Protocol was amended to close enrollment earlier than initially planned (study continued as per plan).”

Drugs

Indications